Now On-Line:

PRRT Insurance Coverage: Update on how Community member Myna was able to have her treatment covered by insurance.

Video from our last meeting on Carcinoid Heart Disease by Dr. Jerome Zacks of Mount Sinai.  The session provided an excellent overall understanding of NETs as well as detailed information regarding Carcinoid Heart Disease.

Videos from the 3rd Theranostics World Congress - These videos were made possible by a grant from NorCal CarciNET Community.  There are over 50 videos in the full Congress, but we have made a smaller channel of videos that we think patients will find of interest. There are many excellent talks including an overview of NETs by Dr. Tom O'Dorisio as well as a patient Q&A session moderated by NorCal CarciNET Community's Josh Mailman.

Registration is now open for Patient Education Day on June 6th at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting in Baltimore. Click here to learn more.  If you live in Baltimore and would like to help NorCal CarciNET Community exhibit at the meeting June 6 - 9, please This email address is being protected from spambots. You need JavaScript enabled to view it. to contact us, we could use your help.

LAcnets and Caring For Carcinoid Foundation will hold a patient education day in Los Angeles on June 27, 2015.

 


In the News:

Dr. Eric Liu has found a new home at the Rocky Mountain Cancer Center in Denver, CO.  We wish Dr. Liu well in his new endeavor.

IPSEN Pharmasuticals has acquired Octreopharm, a company that is currently in clinical trails for Dota-Jr11, a next generation peptide with better receptor binding for use with Ga68 PET/CT and PRRT.

RadioMedix and Areva Med announced a new partnership to develop PRRT therapy using Alpha emitters.  Alpha particles have shorter wave length and greater energy than what is traditionally used for PRRT, potentially offering greater targeting for PRRT in the future. 

University of Iowa has started a Theranostics clinical trial of 68GaDotaToc and 90YDotaToc PRRT.  The trial is open for persons 6 months old - 90 years old with all forms of NETs who have not previously had PRRT.